Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?

Human immunology - 1 Jul 2004

Fernández-Mestre M T, Montagnani S, Layrisse Z

Abstract excerpt

Investigated were two CCR5 gene polymorphisms, the CCR5 Delta 32 deletion and the pCCR5 59029 A-->G promoter point mutation, in 107 ethnically mixed Venezuelan patients serologically positive for Trypanosoma cruzi (34 asymptomatic, 38 arrhythmic, 35 cardiomyopathic). No difference in the distribution of CCR5 Delta 32 among asymptomatic and symptomatic patients was found. We have observed an increase of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chagas Cardiomyopathy
Share to Chagas Disease
Share to Electrophoresis, Agar Gel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homozygote

Share to Point Mutation

Share to Receptors, CCR5

Share to Trypanosoma cruzi

Share to Venezuela

Source

Identifiers

PMID: 15301862
DOI: 10.1016/j.humimm.2004.05.002

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?PMID 15301862Read ↗

Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy.Semantic proximity Read ↗

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy.Semantic proximity Read ↗

Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism.Semantic proximity Read ↗

Evaluation of Apolipoprotein-A1 genetic polymorphisms as biomarkers for Chagas cardiomyopathy in patients from Córdoba, Argentina.Semantic proximity Read ↗

Genetic variants in the chemokines and chemokine receptors in Chagas disease.Semantic proximity Read ↗

Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.Semantic proximity Read ↗

Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.Semantic proximity Read ↗

SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic cardiomyopathy.Semantic proximity Read ↗

Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population.Semantic proximity Read ↗

Genetic polymorphisms in TNFA/TNFR2 genes and Chagas disease in a Colombian endemic population.Semantic proximity Read ↗

Correlation of TcII discrete typing units with severe chronic Chagas cardiomyopathy in patients from various Brazilian geographic regions.Semantic proximity Read ↗

Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.